NEW YORK (GenomeWeb) – Danish life sciences and diagnostics firm Exiqon today announced flat year over year revenues for the first quarter.

For the three months ended March 30, Exiqon reported total revenues of DKK 39 million ($5.9 million). Product revenue increased 7 percent on a currency neutral basis to DKK 30.1 million, while service revenue tumbled 31 percent on a currency neutral basis to DKK 4.6 million, due to market fluctuations. License and grant revenues also remained flat at DKK 4.4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.